Skip to main content
Premium Trial:

Request an Annual Quote

Akadeum, NanoCellect Biomedical Partner to Enhance Rare-Cell Workflows

NEW YORK – Akadeum has partnered with NanoCellect Biomedical to enhance rare-cell workflows, including improving the accuracy and reliability of measurements of certain types of cells.

The team will integrate Ann Arbor, Michigan-based Akadeum's Buoyancy Activated Cell Sorting technology with San Diego-based NanoCellect's Wolf cell-sorting platform to provide customers improved cell isolation, analysis, gentleness, and rare-cell sorting efficiency to single-cell workflows.

The firms aim to enable high-quality single-cell sequencing by first performing gentle cell enrichment using Akadeum's microbubbles, followed by high-precision selection of the targeted cells using NanoCellect's Wolf cell sorter. Users can then load the cells into a microplate for downstream applications and sequencing.

"NanoCellect is focusing on delivering a simple and flexible benchtop cell sorting solution for lab scientists," Jose Morachis, president and cofounder of NanoCellect, said in a statement. "Combining pre-enrichment with Akadeum microbubble technology and gentle cell sorting with the Wolf [instrument] expands the breadth of sample types that can be analyzed, while increasing the cell-sorting efficiency for immune oncology applications."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.